Partners with MEDS Global, the Thai Ministry of Health, Ramathibodi
Hospital and Mahidol University Medical School to Form Center of
Excellence for the Treatment of AF
Cardima, Inc. (OTCBB:CADM), a medical device company focused on
the treatment of atrial fibrillation (AF) and manufacturer of the
Cardima Surgical Ablation System and the REVELATION® line of
therapeutic electrophysiology (EP) catheters, has appointed DKSH
Healthcare as its distributor for Thailand. DKSH will provide Cardima
with an integrated solution, including regulatory, logistics, marketing,
sales, physician training, distribution and after-sales services.
Cardima’s EP Products and Surgical Ablation System have received product
registration approval in Thailand.
Additionally, Cardima is partnering with MEDS Global, the Thai Ministry
of Health, Ramathibodi Hospital and Mahidol University Medical School,
to develop a Center of Excellence in Bangkok, Thailand, for the
treatment of AF. Cardima has successfully completed its second phase of
cardiothoracic surgeon training in Thailand on the use of the Cardima
Surgical Ablation System in a closed-chest setting. This minimally
invasive procedure uses the Cardima Surgical Ablation System via a two
port unilateral approach. The Thai Center of Excellence program will
train physicians in public and private hospitals. These physicians are
expected to treat Thai, as well as international “tourist medicine”
ablation patients.
Commenting on the distribution agreement, Cardima’s CEO Robert Cheney
said, “DKSH has a long history and extensive experience marketing
medical products in the Asia Pacific region, making it an ideal partner
for Cardima in Thailand. We intend to leverage DKSH’s expertise, highly
trained staff and strong existing physician and hospital relationships
to effectively position our products in a market that may otherwise be
difficult for us to enter successfully. We look forward to expanding our
partnership with DKSH Healthcare to other major Asian markets as our
regulatory strategy advances.”
DKSH’s Vice President of Healthcare, Shane Benson commented, “We are
excited to be working with Cardima in developing significant programs
for the treatment of AF in the Asia Pacific region. Our combined
experience in training physicians and setting up treatment programs in
Thailand should provide valuable experience for expansion into
additional Asian markets.
